Brief: Immuneering To Present Preclinical Data At AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics

Immuneering

01/10/2021 12:12

Oct 1 (Reuters) - Immuneering Corp  IMRX.O :
    * IMMUNEERING TO PRESENT PRECLINICAL DATA AT AACR-NCI-EORTC
INTERNATIONAL CONFERENCE ON MOLECULAR TARGETS AND CANCER
THERAPEUTICS
    * IMMUNEERING CORP - ANTICIPATES SUBMISSION OF
INVESTIGATIONAL NEW
DRUG APPLICATION FOR IMM-1-104 TO U.S. FOOD AND DRUG
ADMINISTRATION IN Q1 2022
    * IMMUNEERING - DATA SHOWS BROAD ANTITUMOR ACTIVITY OF
IMM-1-104
ACROSS RAS, RAF MUTANT TUMORS, HIGHLIGHTS MECHANISTIC ASPECTS OF
DUAL MEK INHIBITION

Source text for Eikon:  ID:nGNX2Kt5hQ 
Further company coverage:  IMRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))